Young People Aged 18-25 With Depression or Anxiety Mood Participate in an LLM-based Digital Dialogue Intervention Study

Not Applicable

Completed

• Conditions: Anxiety; LLM-based AI Dialogue Bot; Depression

• Registration Number: NCT06346496
• Lead Sponsor: Institute of Psychology, Chinese Academy of Sciences

Brief Summary

This study is a 28-day randomized controlled trial (RCT). Residents were randomly assigned to an intervention group or a waiting group according to the order in which they were successfully contacted by the staff, and each user was asked to engage in a total of 28 days of dialog intervention with the Douyin companion bot and complete three psychological questionnaires (on Days 1, 14, and 28); however, the intervention group began to receive the dialog intervention after completing the first questionnaire, and the waiting group began to receive the dialog intervention after completing the third questionnaire. During the first four weeks, the waiting group was treated as a blank control. The two groups of subjects completed the three questionnaires at exactly the same point in time. Each user's depression, anxiety, and positive and negative emotions were measured using the Patient Health Questionnaire (PHQ-9), the Generalized Anxiety Disorder Scale (GAD-7) and the Positive and Negative Affect Schedule (PANAS), respectively.

Detailed Description

Not available

Study Timeline

• Status Verified: 2023-10
• Study Start: 2023-11-20
• Primary Completion: 2023-12-18
• Study Completion: 2024-01-15
• Study First Submitted: 2024-03-28
• Study First Submitted QC: 2024-03-28
• Study First Posted: 2024-04-04
• Last Update Submitted: 2024-04-07
• Last Update Posted: 2024-04-09

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 657

Inclusion Criteria

• 18-25 years old
• Proficient in Chinese
• Not dyslexic
• Scoring at least 5 on the PHQ-9 or GAD-7
• Not having a serious physical or diagnosed mental illness

Exclusion Criteria

• Unwilling to continue to participate in the study
• Insufficient clocking in

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Depression	The day before the start of the intervention, day 14 and day 28 after the start of the intervention	Depression was assessed with the Patient Health Questionnaire (PHQ-9). The PHQ-9 contains nine items scored on a scale from 0 (not at all) to 3 (almost every day) based on the self-reported frequency of depressive symptoms in the past 2 weeks. The total score ranges from 0 to 27, and scores above 10 indicate probable depression symptoms.
Anxiety	The day before the start of the intervention, day 14 and day 28 after the start of the intervention	Anxiety was assessed with the Chinese version of the Generalized Anxiety Disorder Scale (GAD-7). The 7 items are rated on a 4-point scale ranging from 0 (never) to 3 (almost every day) to assess the frequency of anxiety symptoms in the past 2 weeks. The total score ranges from 0 to 21, and according to the established criteria, scores above 10 indicate probable anxiety symptoms.
Positive and negative moods	The day before the start of the intervention, day 14 and day 28 after the start of the intervention	Positive and negative moods were assessed with the Positive and Negative Affect Schedule (PANAS). The scale was categorized into two dimensions, positive (PA) and negative (NA), and each dimension was scored independently, with 9 items per dimension. All the items are rated on a 5-point scale ranging from 1 (few) to 5 (very much). The higher the subject's score on a subscale is, the stronger the associated emotion experienced.

Trial Locations

Locations (1)

Institute of Psychology, Chinese Academy of Sciences; 🇨🇳 Beijing, Beijing, China